Some high-tech biotechs claim to be "TechBio" companies. The term signals the use of an automation-heavy approach to biotech. So far, the term is also a major signal for highly risky investments. But ...

Zymergen, an Emeryville-based biotech startup that works at the intersection of robotics, big data and bioengineering, raised $130 million from a range of investors to scale up its microbe-building ...

As you may have heard, there's a new trend in biotech lingo wherein companies call themselves "TechBio" rather than "biotech" to emphasize their forward-thinking about the role of information ...